On April 4, 2025, Mexico’s COFEPRIS announced the revised version of the Good Manufacturing Practices for medical devices (NOM-241-SSA1-2025). This standard establishes the minimum requirements for the design, development, manufacturing, storage, and distribution processes of medical devices. For medical device registration, the submission of GMP certification documents is required for devices ..

In Malaysia, the classification of medical device must be carried out by the manufacturer in accordance with the prescribed manner, based on the level of risk, intended use, and the vulnerability of the human body as stated in Section 3(1) of Act 737. In the event of a dispute between the manufacturer and the Conformity Assessment Body(CAB) regarding the classification of a medical device, the m..

On March 24, 2025, Australia’s Unique Device Identification (UDI) regulatory framework came into effect to enhance patient safety and improve the efficiency of the regulatory system, including the management of post-market safety activities such as recalls. In line with this, the Therapeutic Goods Administration (TGA) released guidance on UDI requirements and compliance with identification timel..

On Mar 18, 2025, the European Commission (EC) published the revised guidance on classification rules for In Vitro Diagnostic Medical Devices Regulation (IVDR) (EU) 2017/746, under MDCG 2020-16 rev.4.  The purpose of this document is to provide guidance to manufacturers, Notified Bodies (NB), and healthcare institutions on how to classify In Vitro Diagnostic Medical Devices before placing them on..

On February 3, 2025, the UK Medicines and Healthcare products Regulatory Agency (MHRA) announced new guidance on Digital Mental Health Technologies (DMHT) due to the increasing use of mental health apps, AI-based assessments, virtual reality therapies, and other digital mental health technologies. This new guidance is aimed at manufacturers.  The guidance document helps manufacturers identify th..

The Korean Ministry of Food and Drug Safety (MFDS) has clarified the scope of medical devices subject to cybersecurity requirements during the medical device approval and review process. It has also defined the applicable security requirements and the range of materials that must be submitted based on the product’s characteristics to ensure the safety management of communicable medical devices. ..

On January 30, 2025, the Thai Food and Drug Administration (Thai FDA) announced new guidelines regarding the change notification process for In Vitro Diagnostic (IVD) medical devices.  1. Addition of Medical Device Items:The application of change for the addition of medical device items is categorized into one of the following four cases: Case 1). Addition of Medical Device Items - When adding r..

On January 31, 2025, the Medical Device Authority (MDA) of Malaysia issued the 2nd edition of the guidelines (MDA/GD/0065) to guide companies on the requirements for pre-market, placement in the market and post-market activities for HIV self-testing kits (HIVST) in the Malaysian market.  The key updated contents of the guidelines are as follows: 1) Regulatory requirements for facilities handling..

On December 17, 2024, the Ministry of Food and Drug Safety (MFDS) of South Korea issued a partial revision of the medical device standard specifications. The revision was made to align with international standards, aiming to enhance the safety and quality levels of medical devices distributed domestically and to prevent potential health risks to the public.  The revisions made to align the medic..

December 13, 2024, The Therapeutic Goods Administration (TGA) of Australia has announced the publication of the Therapeutic Goods (Medical Devices-Information that Must Accompany Application for Inclusion) Amendment Determination (No.3) 2024, which reflects transitional measures for IVD products. This determination allows manufacturers to register IVD products in Australia to meet product regist..